STANFORD UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-11-28
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 36
- Registration Number
- NCT00186628
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2020-04-09
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 30
- Registration Number
- NCT00186667
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Microarray Analysis of Gene Expression in Prostate Tissues
Active, not recruiting
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 2000
- Registration Number
- NCT00186368
- Locations
- 🇺🇸
Stanford University Cancer Center, Stanford, California, United States
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
Phase 1
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2010-03-29
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 10
- Registration Number
- NCT00185835
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant
Phase 1
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 99
- Registration Number
- NCT00186680
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
Phase 1
Terminated
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2010-01-13
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 22
- Registration Number
- NCT00185874
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
Phase 2
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2007-07-11
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00186641
- Locations
- 🇺🇸
Stanford University Cancer Center, Stanford, California, United States
Breathing Regulation Training for Individuals With Panic Disorder
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2011-12-02
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 136
- Registration Number
- NCT00183521
- Locations
- 🇺🇸
Stanford University & VA Health Care System, Palo Alto, California, United States
Acupuncture and Massage for Depression During Pregnancy
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 180
- Registration Number
- NCT00186654
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00186602
- Locations
- 🇺🇸
WomenCARE, Santa Cruz, California, United States
© Copyright 2024. All Rights Reserved by MedPath